U.S. Physical Therapy (USPH)
(Delayed Data from NYSE)
$81.64 USD
-8.36 (-9.29%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $81.47 -0.17 (-0.21%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Brokerage Reports
0 items in cart
U.S. Physical Therapy, Inc. [USPH]
Reports for Purchase
Showing records 1 - 20 ( 20 total )
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Optimized Entry and Exit Levels for USPH 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Steady Progress Through First Half. Outlook Remains Very Favorable. Increasing Forecast for 2014 and 2015. Affirm Buy And Increase Price Target From $40 to $42.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Despite Weather, Q1 Solid. Outlook Remains Very Favorable. Tweaking Forecast For 2014 And Introducing New One For 2015.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Q4 A Lot Stronger Than It Appeared. Despite Weather, Outlook Remains Very Favorable. Tweaking Forecast.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Focus on Workers Compensation. Compliments Fit2Work Nicely. Maintain Conviction on USPH Story. Tweaking Forecast. Affirm Buy Rating and $40 PT
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Fragmented Market. Strong Acquisition and Development Pipeline. Maintain Conviction on USPH Story. Tweaking Forecast.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid 1Q Report. FY13 Guidance Significantly Above Our Estimates. Increasing Forecasts. Affirm Buy Rating and $30 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid 4Q Report. Storms, Flu Impact Q1, Reducing Forecast; Still Believe Investors Should Buy This Stock
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Medicare Reimbursement Adjustment Unexpected. Reducing Forecast; Still Believe Investors Should Buy This Stock
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid 3Q Reported. Key Metrics Suggest The Business Is Performing Well. Sandy Impact Obviously
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
USPH: 2Q EPS Misses But Co. Raises Guidance. Buy & $34 PT.
Provider: COLLIERS SECURITIES
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
USPH:Strong Q1. Co Regaining Traction. Raise PT To $31. Buy.
Provider: COLLIERS SECURITIES
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid Q4 Results Reported. Company Appears To Be Regaining Traction. Affirm Buy Rating And $25 PT. Continue To Recommend Purchase Of This Industry Leader.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Follow Up Comments Post Q3. Affirm Buy Rating And $25 PT. Continue To Recommend Purchase Of This Industry Leader
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
2Q Report In Line With Forecast. 20 Center Acquisition Positive.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: U.S. Physical Therapy, Inc.
Industry: Medical - Outpatient and Home Healthcare
Initiating Coverage With A Buy Rating And $35 Price Target.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
|